Medical Care Technologies Inc. Completes New Version of Tracking Device for Alzheimer's and Dementia
January 14 2010 - 6:30AM
Marketwired
Medical Care Technologies Inc. (OTCBB: MDCE) today announced
completion of version 5.1 of the Trackker(TM) technology for
patients suffering with Alzheimer's and Dementia. MDCE's wireless
Trackker(TM) technology assists in providing safety and behavioral
information for treatment. The purpose behind the Trackker(TM) is
to allow remote access to the Caregiver, medical facility, and the
patient's family to be able to know at all times where patients are
situated. The first target markets are Alzheimer's and Dementia
patients.
The Trackker(TM) uses wireless connections to link a GPS monitor
that is worn by the patient and is linked to a 24/7 monitoring
service. By programming the GPS to certain safety zones, the
service can send a phone or email alert to a caregiver immediately.
The Global Positioning System (GPS) is a worldwide radio-navigation
system formed from a constellation of 24 satellites and their
ground stations. GPS uses these "man-made stars" as reference
points to calculate positions accurate to a matter of meters. GPS
systems typically track patients in open areas outside of buildings
however, the Patient Tracker system has the ability to monitor the
location of patients within and around facilities. At Medical Care
Technologies, we believe that GPS will become almost as basic as
the telephone, we feel it will become a universal utility.
As the Chinese population ages at a rapid rate, diseases like
Alzheimer's and Dementia are on the increase, and MDCE is
developing new ways to assist such patients. The safety and
clinical information provided by our Trackker(TM) technology is
crucial for medical professionals and caregivers to help treat
those who suffer from this type of disease.
According to the Alzheimer's Disease International, as of 2008,
there are an estimated 30 million people with dementia worldwide.
By 2050, it is projected that this figure will have increased to
over 100 million. Much of the increase will be in developing
countries. Already more than 60% of people with dementia live in
developing countries, but by 2040 this will rise to 71%. The
fastest growth in the elderly population is taking place in China,
India, and their south Asian and western Pacific neighbours. In
addition, China has nearly 19 million patients who have been
diagnosed as suffering with Alzheimer's disease.
Ning Wu, President of MCTI, states, "While behaviour changes
hourly or sometimes by the minute in patients with Alzheimer's and
Dementia, our traditional ways of evaluating, documenting and
treating such behaviour can be assisted by utilizing our
Trackker(TM) technology. We are excited to be able to now integrate
the Trackker(TM) to the Tele-Health(TM) Suite which will now offer
new solutions to healthcare and offer comfort to families of those
afflicted with Alzheimer's and Dementia."
About Medical Care Technologies Inc.
Medical Care Technologies Inc. (www.medicaretech.com) is traded
under the symbol MDCE on the OTCBB and is based in London, England.
The Company is in the process of moving its portfolio of oil
resources into medical care technologies. The products/services
that the company hopes to acquire are intended to constitute a
healthcare delivery and wellness site, dedicated to helping Asian
consumers live healthier, more balanced lives. MDCE is planning to
provide advanced connectivity, internationally standardized and
secure business technology and information systems to assist the
Asian health industry -- physicians, pharmacists, medical
institutions, and consumers, in accessing medical resources, health
services, education, wellness and pharmaceutical products
throughout Asia. MDCE is planning to distribute and provide
services at a diverse range of industry-leading product lines in
three segments: Medical Devices, Pharmaceuticals and
Nutraceuticals. Further information on the Company can be found at
www.sec.gov and the company's website at www.medicaretech.com
Safe Harbor Statement
All statements contained in this press release, other than
statements of historical fact, are forward-looking statements,
including those regarding: MDCE's products, services, capabilities,
performance, opportunities, development and business outlook,
guidance on our future financial results and other projections or
measures of our future performance; the amount and timing of the
benefits expected from strategic initiatives and acquisitions or
from deployment of new or updated technologies, products, services
or applications; and other potential sources of additional revenue.
These statements are based on our current plans and expectations
and involve risks and uncertainties that could cause actual future
events or results to be different than those described in or
implied by such forward-looking statements. These risks and
uncertainties include those relating to: lack of operating history,
transitioning from a development company to an operating company,
difficulties in distinguishing MDCE's products and services,
ability to deploy MDCE's services and products, market acceptance
of our products and services; operational difficulties relating to
combining acquired companies and businesses; our ability to form
and maintain mutually beneficial relationships with customers and
strategic partners; changes in economic, political or regulatory
conditions or other trends affecting the healthcare, Internet,
information technology and healthcare and pharmaceutical
industries, and our ability to attract and retain qualified
personnel. Other risks and uncertainties may include, but are not
limited to: lack of or delay in market acceptance and fluctuations
in customer demand, dependence on a limited number of significant
customers, reliance on third party vendors and strategic partners,
ability to meet future capital requirements on acceptable terms,
continuing uncertainty in the global economy, and compliance with
federal and state regulatory requirement. Further information about
these matters can be found in our Securities and Exchange
Commission filings. We expressly disclaim any intent or obligation
to update these forward-looking statements. There can be no
assurance that the acquisition of GUC's assets will close. MDCE
must issue 57,300,000 shares of its common stock to GUC, or GUC's
designees in order to close the acquisition. Accounting for the
anticipated cancelation of 57,300,000 shares by Patricia
Traczykowski, MDCE will have 98,900,000 shares of its common stock
issued and outstanding upon the closing of the acquisition.
For Further Information: Ezra Smith C. Jones Consulting, Inc.
Tel: (727) 771-9500 Fax: (727) 771-9545 Email:
cjones@cjonesconsulting.com Web: www.cjonesconsulting.com
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medical Care Technologies (PK) (USOTC:MDCE)
Historical Stock Chart
From Jul 2023 to Jul 2024